Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2022-11-16 Governance Information
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
New Constitution 45 pages 621.3KB
Governance Information Classification · 100% confidence The document is an ASX announcement dated 17 November 2022 regarding the adoption of a new Constitution by Invion Limited at its Annual General Meeting. The text includes the full table of contents and excerpts of the new Constitution, detailing company governance, share structure, directors' powers, meetings, voting rights, and other corporate governance matters. It is not a financial report, earnings release, or management discussion. It is not a brief announcement or a proxy solicitation but the full text of the new Constitution document itself. This type of document falls under Governance Information (CGR), as it details the company's internal rules, board structure, and governance practices. The document length (15,000 characters) and content confirm it is the full governance document, not just an announcement or summary.
2022-11-16 English
Notification regarding unquoted securities - IVX 9 pages 33.0KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Notification of Issue, Conversion or Payment up of Unquoted Equity Securities' and details the issuance of unquoted securities under an employee incentive scheme by Invion Limited. It includes specifics such as the number of securities issued, issue dates, security descriptions, and references to ASX listing rules. The content is focused on notifying the market and regulatory bodies about the issuance of new unquoted equity securities, not on financial performance, management changes, or other report types. This matches the definition of a Share Issue/Capital Change filing, which covers announcements regarding new share issues or capital changes. The document is substantive and not merely an announcement of a report or a certification, so it is not classified as RPA or RNS. Therefore, the appropriate classification is SHA (Share Issue/Capital Change).
2022-11-16 English
Change of Director's Interest Notice - Thian Chew 2 pages 210.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in a director's relevant interests in securities, including share options and shares held, with specific dates and nature of changes. This type of document is a report of personal share transactions by company directors and executives, commonly known as insider trades. It is not an annual report, audit report, or any other financial or regulatory filing type. The document length is 3796 characters, which is typical for such notices. Therefore, the correct classification is Director's Dealing (DIRS).
2022-11-16 English
Invion Conference Presentation 23 pages 8.6MB
Regulatory Filings
2022-10-26 English
Photosoft Effective Against Superbugs and Other Pathogens 3 pages 286.0KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement from Invion Limited dated 26 October 2022. It reports on the results of in vitro tests of Photosoft[TM] compounds against antibiotic-resistant bacteria and fungi, including MRSA, E. coli, and Candida albicans. The content focuses on scientific test results and potential applications of the technology, rather than financial results, management changes, or regulatory filings. The document is not a full financial report, earnings release, or investor presentation. It is a corporate announcement about research progress and scientific findings. Therefore, it fits best into the category of a Regulatory Filing (RNS) as a general announcement that does not fit other specific categories like earnings, management changes, or capital updates. The document length (7927 characters) and detailed content support this classification with high confidence.
2022-10-25 English
Photosoft shows activity against Dengue in Preliminary Assay 4 pages 334.7KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement from Invion Limited detailing preliminary assay results of their PhotosoftTM compounds against the Dengue virus. It includes scientific data such as EC50 values, cytotoxicity assays, and therapeutic indices, but it is presented as a news release or update rather than a formal financial or regulatory report. There are no financial statements, no mention of annual or quarterly reporting periods, no audit or governance details, and no regulatory certifications. The document is approximately 9,093 characters, which is relatively short and typical for a market announcement. It is clearly an announcement of scientific progress and research results rather than a financial or regulatory filing. Therefore, the most appropriate classification is a Regulatory Filing (RNS), which serves as a general category for miscellaneous announcements that do not fit other specific categories.
2022-10-23 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.